Medicines for rare diseases

    Discover
    ORPHELIA Pharma

    Development of essential medicines in the field of pediatric and rare diseases.

    Read more

    Discover
    Products & Projects

    Focus on deadly epileptic childhood syndromes and refractory and relapsed pediatric cancers.

    therapeutics areas
    Our products

    Latest news

    Visit our news flow to access our press release and latest news.

    9 June 2022

    ORPHELIA Pharma and Gustave Roussy announce the publication in Pharmaceuticals of the scientific work related to the development of the first temozolomide oral suspension for children

    Read More
    31 May 2022

    ORPHELIA reports positive results of the bioequivalence study of KIMOZO® (oral suspension of temozolomide)

    Read More
    11 May 2022

    ORPHELIA Pharma has been awarded a € 1 million grant from Bpifrance to develop a therapy for a rare form of epilepsy

    Read More